CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jilin Aodong Medicine Industry (Group) Co., Ltd. Company Snapshot
Jilin Aodong Medicine Industry (Group) Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jilin Aodong Medicine Industry (Group) Co., Ltd. with three other companies in this sector in CHINA : Dong-E-E-Jiao Co Ltd (2019 sales of 2.96 billion Chinese Renmimbi [US$415.29 million] of which 70% was Pharmaceutical industry), Jiuzhitang Company Limited (3.18 billion Chinese Renmimbi [US$446.19 million] of which 88% was Pharmacuetical Industry), and Zhejiang Hisoar Pharmaceutical Co. Ltd (2.94 billion Chinese Renmimbi [US$412.24 million] of which 55% was Pharmatheutical Industry).

Sales Analysis. Jilin Aodong Medicine Industry (Group) Co., Ltd. reported sales of 3.09 billion Chinese Renmimbi (US$432.81 million) for the year ending December of 2019. This represents a decrease of 7.1% versus 2018, when the company's sales were 3.32 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 24.9% decline in Other Business, from 9.30 million Chinese Renmimbi to 6.99 million Chinese Renmimbi. There were also decreases in sales in Pharmaceutical Manufacturing (down 8.6% to 2.90 billion Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Food (up 31.8% to 131.05 million Chinese Renmimbi) and Other (up 17.6% to 53.30 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jilin Aodong Medicine Industry (Group) Co., Ltd.
  Stock Performance Chart for Jilin Aodong Medicine Industry (Group) Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 15.06
(Figures in Chinese Renmimbi)
1 Week -1.4%   13 Weeks -4.5%  
4 Weeks -10.2%   52 Weeks -7.1%  
 
Jilin Aodong Medicine Industry (Group) Co., Ltd. Key Data:
  Ticker: 000623 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,088,210,858
(Year Ending Jan 2020).
Employees: 3,997
  Currency: Chinese Renmimbi Market Cap: 17,515,313,937
  Fiscal Yr Ends: December Shares Outstanding: 1,163,035,454
  Share Type: A Gu Closely Held Shares: 442,499,608
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.